Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments.

Real time quote data is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

RadNet, Inc. has announced its acquisition of iCAD, Inc. in an all-stock transaction valued at approximately $103 million. This merger aims to enhance RadNet's existing AI-powered cancer detection ...

Greetings. Welcome to the iCAD Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

NASHUA, N.H. (AP) — NASHUA, N.H. (AP) — Icad inc. (ICAD) on Wednesday reported a loss of $854,000 in its fourth quarter. The Nashua, New Hampshire-based company said it had a loss of 3 cents ...

NASHUA, N.H. - iCAD, Inc. (NASDAQ: ICAD), a company specializing in AI-powered breast health solutions, announced today the appointment of Mark Koeniguer as its new Chief Commercial Officer (CCO).